The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
1,000 jobs Number of planned job creations
Announcement Date
12 August 2022
Employment effect (start)
Foreseen end date
Description
US healthcare company Abbott Laboratories will create 1,000 new jobs at a new greenfield manufacturing plant in Kilkenny as well as at its existing plant in Donegal. The company plans to invest €440 million in the two plants. The reason behind the expansion and the job creation is to increase production of the 'FreeStyle Libre' technology for people with diabetes. IDA Ireland supports the investment.
The company started its operations in Ireland in 1946 and currently employs 5,000 people at facilities in Donegal, Tipperary, Dublin, Longford, Sligo and Galway.
Previous business expansion was recorded in the ERM database in 2018, with 500 jobs created (Abbott Ireland-2018-IE).
Eurofound (2022), Abbott Ireland, Business expansion in Ireland, factsheet number 107268, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/107268.